Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
5
×
deals
5
×
johnson & johnson
life sciences
medicaid
5
×
national blog main
national top stories
new york blog main
new york top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
fda
novartis
sanofi
spinal muscular atrophy
startups
affordable care act
aldeyra therapeutics
alzheimer's disease
bill cassidy
biogen
What
roundup
alzheimer’s
bio
drug
gene
aducanumab
age
ahead
ambien
american
amyloid
angst
annual
asco
attendees
attention
bagged
bigger
biggest
billions
biogen
biogen’s
biotech
brammer
camp’s
cancer
cash
chicago
city
clinical
combinations
come
community’s
companies
congress
days
deal
democrats
different
divided
Language
Current search:
medicaid
×
deals
×
" boston top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More